Physician profile
Andrew M Moore
NPI 1437374931
$901.56
in general payments reported to CMS, 2019-2025
9 companies · $90.63 in 2025
The $90.63 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $53.46 · 2021: $198 · 2022: $44.93 · 2023: $252 · 2024: $117 · 2025: $90.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $210.32 | 2021-2025 | Apex 3d, Monkey Rings, Ttc Nail |
| Pinnacle, INC | $159.84 | 2019-2023 | |
| Coastal Medical Technologies LLC | $144.84 | 2023 | |
| Stryker Corporation | $142.53 | 2019-2025 | Inbone, Easyfuse, Valor |
| Kerecis Limited | $137.41 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $37.34 | 2021 | |
| Osteomed LLC | $24.89 | 2022 | |
| Arthrex, INC. | $24.35 | 2019 | |
| Csl Behring | $20.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.